English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 南アフリカの眼科用医薬品市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

南アフリカの眼科用医薬品市場

South African Opthalmology Pharmaceuticals Market

発行 Frost & Sullivan
出版日 2008年06月 商品コード 69034
ページ情報 英文  
価格
US$ 7,500 換算 ¥ 603,525 (税抜) Web Access (Regional License)
US$ 8,000 換算 ¥ 643,760 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This Frost & Sullivan research service titled South African Ophthalmology Pharmaceuticals Market analyses market trends, revenues and growth forecasts for the period 2007 to 2013. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following market segments: glaucoma, anti-infectives, anti-allergy, mydriatic and anti-inflammatory.

This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the complex business universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360° view of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.

Table of Contents

  • 1. Executive Summary
  • 2. Research Objectives, Scope and Methodology
  • 3. South African Ophthalmology Pharmaceuticals Market
    • 1. Glaucoma Market
    • 2. Anti-infective Market
    • 3. Anti-inflammatory Market
    • 4. Anti-allergy Market
  • 4. List of Key Industry Participants
  • 5. Appendix i : PETSLE
  • 6. Appendix ii : About Frost & Sullivan
Back to Top